Exchange Traded Concepts, LLC

SEC CIK: 0001457320
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of RARE by Exchange Traded Concepts, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−657−100.0%	Sold out	Holders
Q1 2021	657	$75.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.